LiverSafe 3D™

In collaboration with Dr. Gordon Keller, one of the world’s leading stem cell researchers, we are developing engineered cell lines and enhancing protocols to control the differentiation of hPSCs into normal, mature, human liver cells for use in a novel liver cell-based biological assay system for predicting liver toxicity and metabolism issues in connection with our drug rescue activities. We refer to this novel human liver cell-based biological assay system as LiverSafe 3D™.